CLOV Clover Health
$4.56
Clover Health (CLOV) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Insider signal
In line
Selling ran in line with CLOV's own trailing one-year pace, with 26% of sale value under a prearranged plan.
Cluster activity
0 buyers in the last 30 days
0 buyers in the last 90 days
6 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
8
32 transactions
Purchases
$0
0 shares
Sales
$5.4M
1,300,191 shares
Net activity
-$5.4M
purchases less sales
How much of that selling was preplanned? 26% planned / 74% discretionary
10b5-1 plan sales
$1.4M
14 transactions · 360,268 shares
Discretionary sales
$4.0M
18 transactions · 939,923 shares
Largest single sale: $1.7M.
Where they traded
Buy
Sell
Dot area is proportional to transaction value.
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Wai Conrad | CEO, Counterpart Health | Sell 10b5-1 | 300,000 | $4.72 | $1.4M | 1,170,056 −20.4% of holding | |
| Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 9,273 | $4.78 | $44.3K | 2,805,367 −0.3% of holding | |
| Soares Karen | Chief Legal Officer | Sell | 6,846 | $4.78 | $32.7K | 1,607,371 −0.4% of holding | |
| OLDAKOWSKI JOSEPH FRANK | VP OF FINANCE AND CONTROLLER | Sell | 20,000 | $5.16 | $103.2K | 279,067 −6.7% of holding | |
| THORNTON JOSEPH CLAY | Interim CFO | Sell | 17,775 | $4.39 | $78.0K | 1,249,526 −1.4% of holding | |
| Toy Andrew | Chief Executive Officer | Sell | 87,798 | $4.65 | $408.3K | 9,459,316 −0.9% of holding | |
| Soares Karen | Chief Legal Officer | Sell 10b5-1 | 51,700 | $4.51 | $233.2K | 1,505,522 −3.3% of holding | |
| Reynoso Jamie L. | CEO, Medicare Advantage | Sell 10b5-1 | 4,839 | $4.53 | $21.9K | 2,814,640 −0.2% of holding | |
| Toy Andrew | Chief Executive Officer | Sell | 62,711 | $4.67 | $292.9K | 9,547,114 −0.7% of holding | |
| Wai Conrad | CEO, Counterpart Health | Sell | 24,215 | $4.67 | $113.1K | 1,145,699 −2.1% of holding | |
| Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 13,119 | $4.67 | $61.3K | 2,819,479 −0.5% of holding | |
| Soares Karen | Chief Legal Officer | Sell | 10,519 | $4.67 | $49.1K | 1,557,222 −0.7% of holding | |
| THORNTON JOSEPH CLAY | Interim CFO | Sell | 4,630 | $4.67 | $21.6K | 1,212,954 −0.4% of holding | |
| Reynoso Jamie L. | CEO, Medicare Advantage | Sell 10b5-1 | 2,384 | $4.68 | $11.2K | 2,832,598 −0.1% of holding | |
| Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 6,229 | $5.26 | $32.8K | 2,834,982 −0.2% of holding | |
| Toy Andrew | Chief Executive Officer | Sell | 313,476 | $5.32 | $1.7M | 9,609,825 −3.2% of holding | |
| Reynoso Jamie L. | CEO, Medicare Advantage | Sell 10b5-1 | 2,360 | $4.78 | $11.3K | 2,841,211 −0.1% of holding | |
| OLDAKOWSKI JOSEPH FRANK | VP OF FINANCE AND CONTROLLER | Sell | 12,102 | $4.86 | $58.8K | 299,067 −3.9% of holding | |
| Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 6,350 | $4.61 | $29.3K | 2,843,571 −0.2% of holding | |
| Soares Karen | Chief Legal Officer | Sell | 4,681 | $4.61 | $21.6K | 1,567,741 −0.3% of holding | |
| Reynoso Jamie L. | CEO, Medicare Advantage | Sell 10b5-1 | 7,289 | $4.91 | $35.8K | 2,849,921 −0.3% of holding | |
| Wai Conrad | CEO, Counterpart Health | Sell 10b5-1 | 220,426 | $3.99 | $879.5K | 1,390,056 −13.7% of holding | |
| Edwards Carladenise Armbrister | Director | Sell | 67,160 | $3.42 | $229.7K | 285,432 −19% of holding | |
| Priest Brady Patrick | CEO of Clover Care Services | Sell | 98,039 | $3.52 | $345.1K | 2,040,222 −4.6% of holding | |
| Reynoso Jamie L. | CEO, Medicare Advantage | Sell 10b5-1 | 5,833 | $1.91 | $11.1K | 2,716,735 −0.2% of holding | |
| Priest Brady Patrick | CEO of Home Care | Sell | 175,000 | $2.17 | $379.8K | 1,998,584 −8.1% of holding | |
| Reynoso Jamie L. | CEO, Medicare Advantage | Sell 10b5-1 | 4,597 | $2.58 | $11.9K | 2,737,700 −0.2% of holding | |
| Reynoso Jamie L. | CEO, Medicare Advantage | Sell 10b5-1 | 2,102 | $2.53 | $5.3K | 2,757,029 −0.1% of holding | |
| Reynoso Jamie L. | CEO, Medicare Advantage | Sell 10b5-1 | 4,913 | $2.61 | $12.8K | 2,767,240 −0.2% of holding | |
| Reynoso Jamie L. | CEO, Medicare Advantage | Sell 10b5-1 | 30,385 | $3.58 | $108.8K | 2,793,411 −1.1% of holding | |
| Reynoso Jamie L. | CEO, Medicare Advantage | Sell 10b5-1 | 16,514 | $2.69 | $44.4K | 2,955,226 −0.6% of holding | |
| Reynoso Jamie L. | CEO, Medicare Advantage | Sell 10b5-1 | 2,012 | $2.65 | $5.3K | 3,043,172 −0.1% of holding | |
| Reynoso Jamie L. | CEO, Medicare Advantage | Sell 10b5-1 | 4,914 | $3.09 | $15.2K | 3,053,890 −0.2% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.